Tian‐Run Lv

533 total citations · 1 hit paper
35 papers, 316 citations indexed

About

Tian‐Run Lv is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tian‐Run Lv has authored 35 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 18 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tian‐Run Lv's work include Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers), Gallbladder and Bile Duct Disorders (14 papers) and Peptidase Inhibition and Analysis (8 papers). Tian‐Run Lv is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers), Gallbladder and Bile Duct Disorders (14 papers) and Peptidase Inhibition and Analysis (8 papers). Tian‐Run Lv collaborates with scholars based in China, United States and Norway. Tian‐Run Lv's co-authors include Fu‐Yu Li, Hai‐Jie Hu, Heng‐Chung Kung, Tiantian Wang, Yanwen Jin, Jun Yu, Wenjie Ma, Fei Liu, Jun-Ke Wang and Zhiqiang He and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular Cancer and Cancer Letters.

In The Last Decade

Tian‐Run Lv

34 papers receiving 314 citations

Hit Papers

Organoids: The current status and biomedical applications 2023 2026 2024 2025 2023 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Organoids: The current status and biomedical applications
    2023 136 citations Hai‐Jie Hu, Heng‐Chung Kung et al. SHILAP Revista de lepidopterología profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tian‐Run Lv China 8 140 104 89 75 62 35 316
Guangyan Lei China 9 77 0.6× 79 0.8× 108 1.2× 56 0.7× 80 1.3× 20 290
Kong Fan-min China 11 114 0.8× 64 0.6× 71 0.8× 71 0.9× 35 0.6× 20 268
Yuan Peng China 11 56 0.4× 86 0.8× 140 1.6× 75 1.0× 17 0.3× 33 314
Peiqing Ma China 9 49 0.3× 72 0.7× 76 0.9× 64 0.9× 15 0.2× 14 287
Bofang Wang China 10 40 0.3× 90 0.9× 133 1.5× 131 1.7× 51 0.8× 39 325
Juntao Huang China 12 60 0.4× 71 0.7× 119 1.3× 92 1.2× 18 0.3× 39 317
Sengwang Fu China 11 99 0.7× 46 0.4× 143 1.6× 84 1.1× 17 0.3× 20 316
Chang Hong China 12 53 0.4× 68 0.7× 123 1.4× 27 0.4× 50 0.8× 35 316
Abhishek Mitra India 6 101 0.7× 165 1.6× 46 0.5× 104 1.4× 24 0.4× 19 263
Ruby Lieshout Netherlands 10 116 0.8× 128 1.2× 90 1.0× 28 0.4× 76 1.2× 11 311

Countries citing papers authored by Tian‐Run Lv

Since Specialization
Citations

This map shows the geographic impact of Tian‐Run Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian‐Run Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian‐Run Lv more than expected).

Fields of papers citing papers by Tian‐Run Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tian‐Run Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian‐Run Lv. The network helps show where Tian‐Run Lv may publish in the future.

Co-authorship network of co-authors of Tian‐Run Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Tian‐Run Lv. A scholar is included among the top collaborators of Tian‐Run Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tian‐Run Lv. Tian‐Run Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Wei, Tian‐Run Lv, Lang Bai, & Hong Tang. (2024). The significance of neuroendocrine component in cases with intrahepatic cholangiocarcinoma: A SEER-based retrospective cohort study. Current Problems in Surgery. 61(11). 101608–101608. 4 indexed citations
2.
He, Zhiqiang, Tian‐Run Lv, Jun-Ke Wang, et al.. (2024). Exosomal long non-coding RNA TRPM2-AS promotes angiogenesis in gallbladder cancer through interacting with PABPC1 to activate NOTCH1 signaling pathway. Molecular Cancer. 23(1). 65–65. 27 indexed citations
3.
4.
Lv, Tian‐Run, Jun-Ke Wang, Fu‐Yu Li, & Hai‐Jie Hu. (2024). Prognostic factors for resected cases with gallbladder carcinoma: a systematic review and meta-analysis. International Journal of Surgery. 110(7). 4342–4355. 2 indexed citations
5.
6.
Lv, Tian‐Run, Hongjun Lin, Hai‐Jie Hu, & Fu‐Yu Li. (2024). The effectiveness of adequate lymphadenectomy in radically-resected cases with pathologically-confirmed node-negative biliary tract cancers: A SEER-based retrospective cohort study. Current Problems in Surgery. 61(8). 101500–101500. 4 indexed citations
7.
He, Zhiqiang, Tian‐Run Lv, Jun-Ke Wang, et al.. (2024). PP4R1 promotes glycolysis and gallbladder cancer progression through facilitating ERK1/2 mediated PKM2 nuclear translocation. Cancer Letters. 586. 216677–216677. 7 indexed citations
8.
Wang, Jun-Ke, Wenjie Ma, Hai‐Jie Hu, et al.. (2024). The prognostic value of combined preoperative PLR and CA19-9 in patients with resectable gallbladder cancer. Updates in Surgery. 76(4). 1235–1245. 1 indexed citations
9.
Yang, Siqi, et al.. (2023). Is tumor necrosis a clinical prognostic factor in hepato‐biliary‐pancreatic cancers? A systematic review and meta‐analysis. Cancer Medicine. 12(10). 11166–11176. 5 indexed citations
10.
Hu, Hai‐Jie, Heng‐Chung Kung, Tiantian Wang, et al.. (2023). Organoids: The current status and biomedical applications. SHILAP Revista de lepidopterología. 4(3). 136 indexed citations breakdown →
11.
Hu, Hai‐Jie, et al.. (2023). The influence of resection margin width in patients with intrahepatic cholangiocarcinoma: a meta-analysis. World Journal of Surgical Oncology. 21(1). 16–16. 8 indexed citations
12.
Lv, Tian‐Run, et al.. (2023). The significance of peri-neural invasion in patients with resected hilar cholangiocarcinoma: A single-center experience in China. Asian Journal of Surgery. 47(1). 274–280. 1 indexed citations
13.
Lv, Tian‐Run, Hai‐Jie Hu, Wenjie Ma, et al.. (2023). Meta-analysis of prognostic factors for overall survival and disease-free survival among resected patients with combined hepatocellular carcinoma and cholangiocarcinoma. European Journal of Surgical Oncology. 50(1). 107279–107279. 4 indexed citations
14.
15.
Lv, Tian‐Run, et al.. (2023). Neuroendocrine Component in Extrahepatic Cholangiocarcinoma is Associated with Better Survival: Data from the SEER Study. Advances in Therapy. 40(9). 4032–4041. 2 indexed citations
16.
Hu, Hai‐Jie, et al.. (2022). The effect of secondary resection for patients with primary positive ductal margin of hilar cholangiocarcinoma: An updated meta-analysis. Asian Journal of Surgery. 45(9). 1780–1782. 1 indexed citations
17.
Hu, Hai‐Jie, Tian‐Run Lv, Fei Liu, et al.. (2022). Clinicopathological characteristics and outcome of primary sarcomatoid carcinoma of the gallbladder. Frontiers in Oncology. 12. 1009673–1009673. 3 indexed citations
18.
Lv, Tian‐Run, et al.. (2022). Sarcomatoid hepatocellular carcinoma versus conventional hepatocellular carcinoma: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology. 148(7). 1685–1696. 6 indexed citations
19.
Lv, Tian‐Run, et al.. (2022). The consistencies and inconsistencies between distal cholangiocarcinoma and pancreatic ductal adenocarcinoma: A systematic review and meta-analysis. Frontiers in Oncology. 12. 1042493–1042493. 4 indexed citations
20.
Lv, Tian‐Run, Fei Liu, Hai‐Jie Hu, et al.. (2021). The role of extra-hepatic bile duct resection in the surgical management of gallbladder carcinoma. A first meta-analysis. European Journal of Surgical Oncology. 48(3). 482–491. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guangyan Lei Breakdown of academic impact, for papers by Kong Fan-min Breakdown of academic impact, for papers by Yuan Peng Breakdown of academic impact, for papers by Peiqing Ma Breakdown of academic impact, for papers by Bofang Wang Breakdown of academic impact, for papers by Juntao Huang Breakdown of academic impact, for papers by Sengwang Fu Breakdown of academic impact, for papers by Chang Hong Breakdown of academic impact, for papers by Abhishek Mitra Breakdown of academic impact, for papers by Ruby Lieshout
Rankless by CCL
2026